PFN3
geneOn this page
Summary
PFN3 (profilin 3, HGNC:18627) is a protein-coding gene on chromosome 5q35.3, encoding Profilin-3 (P60673). Binds to actin and affects the structure of the cytoskeleton.
The product of this gene belongs to the profilin family of proteins. This protein binds to actin and affects the structure of the cytoskeleton. It also may be involved in spermatogenesis. It is a single exon gene.
Source: NCBI Gene 345456 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 30 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_001029886
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18627 |
| Approved symbol | PFN3 |
| Name | profilin 3 |
| Location | 5q35.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196570 |
| Ensembl biotype | protein_coding |
| OMIM | 612812 |
| Entrez | 345456 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000358571
RefSeq mRNA: 1 — MANE Select: NM_001029886
NM_001029886
CCDS: CCDS34301
Canonical transcript exons
ENST00000358571 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001410937 | 177400109 | 177400661 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 95.55.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0435 / max 24.8097, expressed in 9 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 65085 | 0.0223 | 8 |
| 65083 | 0.0140 | 3 |
| 65084 | 0.0040 | 3 |
| 65082 | 0.0033 | 2 |
Top tissues by expression
104 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.55 | gold quality |
| right testis | UBERON:0004534 | 81.05 | gold quality |
| left testis | UBERON:0004533 | 80.80 | gold quality |
| testis | UBERON:0000473 | 78.60 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 52.53 | gold quality |
| cortical plate | UBERON:0005343 | 51.80 | gold quality |
| right lobe of liver | UBERON:0001114 | 46.95 | gold quality |
| kidney | UBERON:0002113 | 46.31 | gold quality |
| liver | UBERON:0002107 | 42.67 | gold quality |
| metanephros cortex | UBERON:0010533 | 40.79 | gold quality |
| cortex of kidney | UBERON:0001225 | 40.41 | gold quality |
| bone marrow cell | CL:0002092 | 38.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 33.07 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 31.20 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 27.98 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| leukocyte | CL:0000738 | 27.42 | silver quality |
| monocyte | CL:0000576 | 27.40 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| frontal cortex | UBERON:0001870 | 26.96 | silver quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.16 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Porfilin 3 has the actin-binding site conserved, but retains only approximately half of the common poly-L-proline binding site. (PMID:19419568)
- Profilin 3 genetic architecture in glioma formalin fixed paraffin embedded (FFPE) archive. (PMID:33775850)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pfn3 | ENSMUSG00000044444 |
| rattus_norvegicus | Pfn3 | ENSRNOG00000082948 |
Paralogs (2): PFN2 (ENSG00000070087), PFN1 (ENSG00000108518)
Protein
Protein identifiers
Profilin-3 — P60673 (reviewed: P60673)
Alternative names: Profilin III
All UniProt accessions (1): P60673
UniProt curated annotations — full annotation on UniProt →
Function. Binds to actin and affects the structure of the cytoskeleton. Slightly reduces actin polymerization. Binds to poly-L-proline, phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and phosphatidylinositol 4-phosphate (PtdIns(4)P). May be involved in spermatogenesis.
Subunit / interactions. Interacts with ACTRT3.
Subcellular location. Cytoplasm. Cytoskeleton. Nucleus.
Tissue specificity. Testis specific.
Similarity. Belongs to the profilin family.
RefSeq proteins (1): NP_001025057* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005454 | Profilin1/2/3_vertebrate | Family |
| IPR005455 | PFN_euk | Family |
| IPR036140 | PFN_sf | Homologous_superfamily |
| IPR048278 | PFN | Family |
Pfam: PF00235
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P60673-F1 | 94.41 | 0.91 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 45 (showing top):
GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY, GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY, GOMF_ACTIN_BINDING, GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH, KEGG_REGULATION_OF_ACTIN_CYTOSKELETON
GO Biological Process (3): actin cytoskeleton organization (GO:0030036), regulation of actin filament polymerization (GO:0030833), positive regulation of actin filament bundle assembly (GO:0032233)
GO Molecular Function (2): actin binding (GO:0003779), lipid binding (GO:0008289)
GO Cellular Component (3): nucleus (GO:0005634), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoskeleton organization | 1 |
| actin filament-based process | 1 |
| regulation of actin polymerization or depolymerization | 1 |
| actin filament polymerization | 1 |
| regulation of protein polymerization | 1 |
| regulation of actin filament bundle assembly | 1 |
| positive regulation of cellular component biogenesis | 1 |
| actin filament bundle assembly | 1 |
| positive regulation of cytoskeleton organization | 1 |
| positive regulation of supramolecular fiber organization | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1781 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PFN3 | VASP | P50552 | 998 |
| PFN3 | ACTB | P02570 | 988 |
| PFN3 | WAS | P42768 | 980 |
| PFN3 | GSN | P06396 | 955 |
| PFN3 | XPO6 | Q96QU8 | 952 |
| PFN3 | APBB1IP | Q7Z5R6 | 951 |
| PFN3 | CFL2 | Q9Y281 | 948 |
| PFN3 | CFL1 | P23528 | 948 |
| PFN3 | TMSB4X | P01253 | 934 |
| PFN3 | WASL | O00401 | 899 |
| PFN3 | FMNL1 | O95466 | 887 |
| PFN3 | SCIN | Q9Y6U3 | 879 |
| PFN3 | ACTR2 | P61160 | 867 |
| PFN3 | ACTG1 | P02571 | 862 |
| PFN3 | RAPH1 | Q70E73 | 849 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PFN3 | ACTB | psi-mi:“MI:0914”(association) | 0.350 |
| TCHHL1 | PFN3 | psi-mi:“MI:0914”(association) | 0.350 |
| PFN3 | POTEJ | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): ACTC1 (Affinity Capture-MS), ACTB (Affinity Capture-MS), PFN3 (Affinity Capture-MS), ACTBL2 (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), TUBA3C (Affinity Capture-MS), CBWD1 (Affinity Capture-MS), POTEJ (Affinity Capture-MS), TUBA1A (Affinity Capture-MS)
ESM2 similar proteins: A4KA36, A4KA41, A4KA54, A4KA55, A4KA57, A4KA61, A7S6M8, A9UMU8, M0RCP6, P02584, P07274, P07737, P0C0Y3, P25843, P35080, P39825, P49842, P52184, P53696, P60673, P62962, P62963, Q09430, Q0P3X8, Q0VGL1, Q2M2U3, Q2NKT1, Q32PB1, Q42418, Q4R4P8, Q5IRJ7, Q5R483, Q5R4E2, Q64LH2, Q68HB4, Q6QEJ7, Q6VH22, Q8CF66, Q8GT39, Q8NHR9
Diamond homologs: M0RCP6, P02584, P07737, P35080, P60673, P62962, P62963, Q09430, Q32PB1, Q4R4P8, Q5R4E2, Q9DAD6, Q9EPC6, Q9JJV2, A0A7H0DND9, O57243, P0DSW5, P0DSW6, P68695, Q6RZE1, Q76ZN5, Q775N7, Q77DS0, Q77TH1, Q80DT4, Q8JL78, Q8V2L6, Q8V4T7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
30 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 26 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 979537 | GRCh37/hg19 5q35.2-35.3(chr5:175394616-177436413)x3 | Pathogenic |
| 1807722 | GRCh37/hg19 5q35.2-35.3(chr5:176547912-177126647)x3 | Likely pathogenic |
SpliceAI
112 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:177400490:G:C | donor_gain | 0.9700 |
| 5:177400437:T:TA | donor_gain | 0.9400 |
| 5:177400486:CGCAG:C | donor_gain | 0.8600 |
| 5:177400521:T:TA | donor_gain | 0.8000 |
| 5:177400434:ACCT:A | donor_gain | 0.7800 |
| 5:177400435:CCTC:C | donor_gain | 0.7800 |
| 5:177400430:GCCCA:G | donor_loss | 0.7300 |
| 5:177400431:CCCAC:C | donor_loss | 0.7300 |
| 5:177400432:CCACC:C | donor_loss | 0.7300 |
| 5:177400433:CA:C | donor_loss | 0.7300 |
| 5:177400434:A:AG | donor_loss | 0.7300 |
| 5:177400435:C:A | donor_loss | 0.7300 |
| 5:177400489:AG:A | donor_gain | 0.7300 |
| 5:177400436:C:G | donor_loss | 0.6800 |
| 5:177400386:AGGC:A | donor_gain | 0.6700 |
| 5:177400489:A:AC | donor_gain | 0.6700 |
| 5:177400386:AGG:A | donor_gain | 0.6600 |
| 5:177400481:C:T | donor_gain | 0.6600 |
| 5:177400564:T:A | donor_gain | 0.6600 |
| 5:177400392:G:A | donor_gain | 0.6500 |
| 5:177400497:T:TA | donor_gain | 0.6300 |
| 5:177400408:G:A | donor_gain | 0.6100 |
| 5:177400485:A:C | donor_gain | 0.5900 |
| 5:177400438:C:A | donor_gain | 0.5800 |
| 5:177400324:CGCCG:C | donor_gain | 0.5700 |
| 5:177400431:C:CA | donor_gain | 0.5600 |
| 5:177400484:CACG:C | donor_gain | 0.5500 |
| 5:177400326:CCG:C | donor_gain | 0.5300 |
| 5:177400557:TAG:T | donor_gain | 0.5300 |
| 5:177400558:AGA:A | donor_gain | 0.5300 |
AlphaMissense
870 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:177400449:A:T | I43N | 0.953 |
| 5:177400512:A:T | I22N | 0.949 |
| 5:177400515:G:T | A21D | 0.947 |
| 5:177400350:T:A | D76V | 0.946 |
| 5:177400377:C:T | G67E | 0.936 |
| 5:177400567:A:G | W4R | 0.936 |
| 5:177400567:A:T | W4R | 0.936 |
| 5:177400449:A:G | I43T | 0.935 |
| 5:177400481:C:A | W32C | 0.933 |
| 5:177400481:C:G | W32C | 0.933 |
| 5:177400215:A:T | L121H | 0.929 |
| 5:177400351:C:G | D76H | 0.929 |
| 5:177400350:T:G | D76A | 0.928 |
| 5:177400449:A:C | I43S | 0.926 |
| 5:177400359:A:T | V73D | 0.925 |
| 5:177400522:C:G | D19H | 0.923 |
| 5:177400212:T:A | N122I | 0.922 |
| 5:177400520:G:C | D19E | 0.917 |
| 5:177400520:G:T | D19E | 0.917 |
| 5:177400516:C:G | A21P | 0.916 |
| 5:177400349:G:C | D76E | 0.913 |
| 5:177400349:G:T | D76E | 0.913 |
| 5:177400425:A:T | L51H | 0.912 |
| 5:177400354:G:T | R75S | 0.910 |
| 5:177400243:C:G | G112R | 0.908 |
| 5:177400521:T:A | D19V | 0.907 |
| 5:177400356:A:G | I74T | 0.906 |
| 5:177400483:A:G | W32R | 0.904 |
| 5:177400483:A:T | W32R | 0.904 |
| 5:177400280:G:C | C99W | 0.902 |
dbSNP variants (sampled 300 via entrez): RS1000253382 (5:177402599 G>A), RS1001326017 (5:177401256 G>T), RS1001479722 (5:177401482 T>C), RS1002201363 (5:177401109 A>T), RS1002229639 (5:177399729 G>A), RS1002732466 (5:177399983 T>C,G), RS1003208101 (5:177399881 G>A), RS1006054767 (5:177400072 TC>T,TCC), RS1006587732 (5:177400345 G>A,C,T), RS1007642333 (5:177400716 G>A,T), RS1008975357 (5:177402198 G>A,T), RS1009927611 (5:177400948 A>T), RS1010403616 (5:177402511 C>G,T), RS1011078817 (5:177399853 A>G,T), RS1011827952 (5:177401039 G>A)
Disease associations
OMIM: gene MIM:612812 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000649_23 | Chronic kidney disease | 1.000000e-14 |
| GCST001432_1 | Nephrolithiasis | 9.000000e-12 |
| GCST001639_21 | Metabolite levels | 3.000000e-14 |
| GCST005956_15 | Waist-to-hip ratio adjusted for BMI | 1.000000e-07 |
| GCST005957_13 | Waist-to-hip ratio adjusted for BMI (age <50) | 3.000000e-07 |
| GCST005962_42 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 1.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004723 | coronary artery calcification |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Ivermectin | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): nephrolithiasis